
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
A study presented at the International AIDS Society Conference on HIV Pathogenesis and Treatment shows that a once-daily regimen containing Sustiva, Bristol-Myers Squibb's nonnucleoside reverse transcriptase inhibitor, is as effective in continuing to suppress HIV in people with undetectable viral loads as ongoing protease inhibitor therapy. The Food and Drug Administration granted marketing approval for Emtriva (emtricitabine), Gilead Sciences' nucleoside reverse transcriptase inhibitor, formerly known as FTC, on July 2. Emtriva is taken once daily, with or without food. The FDA has approved Advate, Baxter Healthcare's genetically engineered blood clotting factor, for the prevention and control of bleeding episodes in people with hemophilia A. Advate is the first hemophilia treatment made without any added human or animal plasma proteins. OraSure Technologies has announced Mexico's Ministry of Health's approval to market its OraQuick Rapid HIV-1 Antibody Test in the country. OraQuick can detect HIV antibodies in about 20 minutes. GlaxoSmithKline announced in July that it is ending a 200-person study of a combination anti-HIV drug regimen including Ziagen, Viread, and Epivir because of a high rate of failure seen after 16 weeks of treatment. VaxGen officials have said the company might stop funding its clinical trial of the experimental HIV vaccine AIDSVAX in Thailand before final data is collected because of financial constraints. A separate Phase III trial showed the vaccine is largely ineffective at preventing HIV infections in the general population, though it may be more useful for African-Americans and Asians. New data from a Phase III clinical trial of Fuzeon, the world's first HIV fusion inhibitor, developed by Roche and Trimeris, shows that two thirds of treatment-experienced patients who began a Fuzeon-based regimen were able to achieve undetectable viral loads. The companies also announced that supplies of the drug for 2003 will be higher than initially projected, with enough medication available to treat about 18,000 patients by the end of the year. A study in the June issue of the journal AIDS shows that Reyataz, the newly approved protease inhibitor developed by Bristol-Myers Squibb, is easier on the heart than Norvir when used in a salvage regimen. Reyataz lowered both bad cholesterol and triglyceride levels. A new study has shown that symptoms of depression can be eased by switching from a protease inhibitor or nonnucleoside reverse transcriptase inhibitor to Kaletra, a second-generation protease inhibitor made by Abbott Laboratories. Researchers in Thailand report that reducing the dosing level of d4T, the nucleoside reverse transcriptase inhibitor sold as Zerit in the United States by Bristol-Myers Squibb, can improve lipoatrophy while still maintaining viral suppression in HIV-positive adults. Researchers at Montreal's Theratechnologies report that studies of the peptide TH9507 in elderly and diabetes patients have shown that the compound stimulates the production of human growth hormone, which in turn helps speed up fat loss. The company plans a clinical trial to determine if the peptide is effective in combating antiretroviral-related lipodystrophy in HIV-positive adults. A study presented at the International AIDS Society Conference on HIV Pathogenesis and Treatment shows that treatment with Avandia, GlaxoSmithKline's antidiabetes medication, can help improve insulin sensitivity and lipoatrophy in HIV-positive patients. A study presented at the International AIDS Society Conference on HIV Pathogenesis and Treatment shows that psyllium, calcium carbonate, and loperamide supplements'along with dietary changes'can reduce diarrhea caused by Viracept, marketed by Agouron Pharmaceuticals. A study in the July 25 issue of the journal AIDS shows that treatment with Arava, an immunomodulatory treatment for rheumatoid arthritis developed by Aventis Pharmaceuticals, may boost the anti-HIV activity of AZT, sold in the United States as Retrovir, by GlaxoSmithKline. A study presented at the International AIDS Society Conference on HIV Pathogenesis and Treatment shows that switching from a protease inhibitor'based regimen to one containing Viramune, Boehringer Ingelheim's nonnucleoside reverse transcriptase inhibitor, maintains long-term viral suppression and immunological improvements. A study presented at the International AIDS Society Conference on HIV Pathogenesis and Treatment shows a treatment regimen including low-dose Norvir and Reyataz, the newly approved protease inhibitor developed by Bristol-Myers Squibb, is as effective as a regimen containing the protease inhibitor Kaletra. Data from a Phase III trial of the recently approved HIV nucleoside reverse transcriptase inhibitor Emtriva, developed by Gilead Sciences, shows that the once-daily drug is more potent than Bristol-Myers Squibb's Zerit in suppressing HIV viral loads and boosting CD4-cell counts. Researchers have announced the development of a flexible intravaginal ring that time-releases anti-HIV drugs and may protect users against HIV infection. The ring, similar to a diaphragm, can be used continuously for six to 12 months.
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
Plus: Featured Video
Latest Stories
Grindr is reminding us why jockstraps are so sexy and iconic
May 02 2025 5:36 PM
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM
HRC holds 'die-in' to protest Trump health care cuts
April 28 2025 2:11 PM
Two right-wing Supreme Court justices signal they may uphold access to PrEP and more
April 21 2025 4:10 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
500,000 Children at Risk: PEPFAR Funding Crisis
April 08 2025 3:51 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM